AAAAAA

   
Results: 1-16 |
Results: 16
HANTAVIRUS PULMONARY SYNDROME
Authors: SIMPSON SQ
Citation: Sq. Simpson, HANTAVIRUS PULMONARY SYNDROME, Heart & lung, 27(1), 1998, pp. 51-57
SUCCESSFUL TREATMENT OF ADULTS WITH SEVERE HANTAVIRUS PULMONARY SYNDROME WITH EXTRACORPOREAL MEMBRANE-OXYGENATION
Authors: CROWLEY MR KATZ RW KESSLER R SIMPSON SQ LEVY H HALLIN GW CAPPON J KRAHLING JB WERNLY J
Citation: Mr. Crowley et al., SUCCESSFUL TREATMENT OF ADULTS WITH SEVERE HANTAVIRUS PULMONARY SYNDROME WITH EXTRACORPOREAL MEMBRANE-OXYGENATION, Critical care medicine, 26(2), 1998, pp. 409-414
INTERLEUKIN-8 CONCENTRATION PREDICTS THE NEUTROPHIL COUNT IN MIDDLE-EAR EFFUSION
Authors: NASSIF PS SIMPSON SQ IZZO AA NICKLAUS PJ
Citation: Ps. Nassif et al., INTERLEUKIN-8 CONCENTRATION PREDICTS THE NEUTROPHIL COUNT IN MIDDLE-EAR EFFUSION, The Laryngoscope, 107(9), 1997, pp. 1223-1227
PLEURAL FLUID CHARACTERISTICS IN HANTAVIRUS PULMONARY SYNDROME
Authors: BUSTAMANTE EA LEVY H SIMPSON SQ
Citation: Ea. Bustamante et al., PLEURAL FLUID CHARACTERISTICS IN HANTAVIRUS PULMONARY SYNDROME, Chest, 112(4), 1997, pp. 1133-1136
NASAL DEPOSITION OF ULTRAFINE PARTICLES IN HUMAN VOLUNTEERS AND ITS RELATIONSHIP TO AIRWAY GEOMETRY
Authors: CHENG YS YEH HC GUILMETTE RA SIMPSON SQ CHENG KH SWIFT DL
Citation: Ys. Cheng et al., NASAL DEPOSITION OF ULTRAFINE PARTICLES IN HUMAN VOLUNTEERS AND ITS RELATIONSHIP TO AIRWAY GEOMETRY, Aerosol science and technology, 25(3), 1996, pp. 274-291
CARDIOPULMONARY MANIFESTATIONS OF HANTAVIRUS PULMONARY SYNDROME
Authors: HALLIN GW SIMPSON SQ CROWELL RE JAMES DS KOSTER FT MERTZ GJ LEVY H
Citation: Gw. Hallin et al., CARDIOPULMONARY MANIFESTATIONS OF HANTAVIRUS PULMONARY SYNDROME, Critical care medicine, 24(2), 1996, pp. 252-258
USE OF PREDICTED RISK OF MORTALITY TO EVALUATE THE EFFICACY OF ANTICYTOKINE THERAPY IN SEPSIS
Authors: KNAUS WA HARRELL FE LABRECQUE JF WAGNER DP PRIBBLE JP DRAPER EA FISHER CJ SOLL L ASTIZ M RACKOW EC CARPATI C BALK RA FRIEDMAN B MURE AJ SHAPIRO E MELHOM L SHAPIRO MJ TAYLOR R KEEGAN M OBRIEN J GREENMAN RL SCHEIN R PENA M WASSERLOUF M IBERTI TJ OROPELLO J BENJAMIN E DELGUIDICE R EMMANUEL G LIE T ANDERSON L MARSHALL J DEMAJO W ROTSTEIN O FOSTER D ABRAHAM E MIDDLETON H PERRY C LEVY H FRY DE SIMPSON SQ CROWELL RE NEIDHART M STEVENS D COFFMAN T NARASIMHAN N MERRICK DK BERQUIST W MATZEL K HUEBLER M FOULKE G ALBERTSON T WALBY W ALLEN R BAUGHMAN R HASSELGREN PO FINK MP FAVORITO F THOMAS BT CORBIN R SHELLHORSE GY FRAZIER A WHITE S GARRARD C ACOURT C GERVICH D BRASE R BAGDAHN A COONEY R SMITH JS VINCENT JL FRIEDMAN G BERLOT G FLETCHER JR WILLIAMS MD WRIGHT TF JOHNSON S FEILD C WOLF K MACINTYRE N DUBIN H DURKIN M STAUBACH KH FEIN AM SCHULMAN DB NIEDERMAN MS CHALFIN DB VANLEEUVEN PAM BANDER J IMM A BERNARD G NELSON L STROUD M SAFCSAK K CERRA F RINDAL J MANN H HALPERN N ALICEA M SIBBALD WJ MARTIN CM RUTLEDGE FS PETTI K RUSSELL J KRUGER R DRUMMOND A FISHER CS LANGE P SELFERT T DUROCHER A TENAILLON A BOITEAU R LHERM T LOWRY S COYLE SM BARIE PS DEMARIA E REINES HD SNYDMAN D SCHWAITZBERG S NASRAWAY S GRINDLINGER J SUMMER W DEBOISBLANC B WAHL M ALESTIG K GROSSMAN J MAKI D PAZ HL WEINER M BIHARI D BLEICHNER G DAHN M HALL J WENZEL RP GROSSERODE M COSTIGAN M MILESKI W WEIGELT J YESTON N IRIZARRY C ROSS J ROBBINS J SHELLY MP NIGHTINGALE P OWEN K SANDSTEDT S BERG S SIMON G SENEFF M CONRY K ZIMMERMAN JL DELLINGER RP JOHNSTON R ALLEE P GRANDE PO MYHRE E DHAINAUT JF HAMY I MIRA JP HARMON J WHITE J MCKIE L SILVERMAN H TUMA P BENNETT D LAURELL MH JACOBS S ASH S OPAL SM SLOTMAN GJ IBERTI TJ SADOFF JC STILES DM THOMPSON B PRIOR MJ KNATTERUD G TERRIN M KUFERA J WILKENS P RA K MONROE L SPRUNG C HAMILTON CM MATTHAY R MCCABE W TONASCIA J WIEDMAN H WITTES J THOMPSON BW LABRECQUE JF CATALANO MA CAMPION GV CROFT CR LUSTICK R LOOKABAUGH J GORDON GS NOE L BLOEDOW D SMITH CG BRANNON D KUSH R NG D MOORE E BAZEMORE K GALVAN M WAGNER D HARRELL F STABLEIN D
Citation: Wa. Knaus et al., USE OF PREDICTED RISK OF MORTALITY TO EVALUATE THE EFFICACY OF ANTICYTOKINE THERAPY IN SEPSIS, Critical care medicine, 24(1), 1996, pp. 46-56
IN-VIVO MEASUREMENTS OF NASAL AIRWAY DIMENSIONS AND ULTRAFINE AEROSOLDEPOSITION IN THE HUMAN NASAL AND ORAL AIRWAYS
Authors: CHENG KH CHENG YS YEH HC GUILMETTE RA SIMPSON SQ YANG YH SWIFT DL
Citation: Kh. Cheng et al., IN-VIVO MEASUREMENTS OF NASAL AIRWAY DIMENSIONS AND ULTRAFINE AEROSOLDEPOSITION IN THE HUMAN NASAL AND ORAL AIRWAYS, Journal of aerosol science, 27(5), 1996, pp. 785-801
SOCIAL IMPACT OF RESPIRATORY-INFECTIONS
Authors: SIMPSON SQ JONES PW DAVIES PDO CUSHING A
Citation: Sq. Simpson et al., SOCIAL IMPACT OF RESPIRATORY-INFECTIONS, Chest, 108(2), 1995, pp. 63-69
HANTAVIRUS PULMONARY SYNDROME
Authors: LEVY H SIMPSON SQ
Citation: H. Levy et Sq. Simpson, HANTAVIRUS PULMONARY SYNDROME, American journal of respiratory and critical care medicine, 149(6), 1994, pp. 1710-1713
HEAT-KILLED PNEUMOCOCCI AND PNEUMOCOCCAL CAPSULAR POLYSACCHARIDES STIMULATE TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION BY MURINE MACROPHAGES
Authors: SIMPSON SQ SINGH R BICE DE
Citation: Sq. Simpson et al., HEAT-KILLED PNEUMOCOCCI AND PNEUMOCOCCAL CAPSULAR POLYSACCHARIDES STIMULATE TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION BY MURINE MACROPHAGES, American journal of respiratory cell and molecular biology, 10(3), 1994, pp. 284-289
HANTAVIRUS PULMONARY SYNDROME - RECOGNITION AND EMERGENCY DEPARTMENT MANAGEMENT
Authors: DULL SM BRILLMAN JC SIMPSON SQ SKLAR DP
Citation: Sm. Dull et al., HANTAVIRUS PULMONARY SYNDROME - RECOGNITION AND EMERGENCY DEPARTMENT MANAGEMENT, Annals of emergency medicine, 24(3), 1994, pp. 530-536
RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF PATIENTS WITH SEPSIS SYNDROME - RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Authors: FISHER CJ DHAINAUT JFA OPAL SM PRIBBLE JP BALK RA SLOTMAN GJ IBERTI TJ RACKOW EC SHAPIRO MJ GREENMAN RL REINES HD SHELLY MP THOMPSON BW LABRECQUE JF CATALANO MA KNAUS WA SADOFF JC ASTIZ M CARPATI C BONE RC FREIDMAN B MURE AJ BRATHWAITE C SHAPIRO E MELHORN L TAYLOR R KEEGAN M OBRIEN J SCHEIN R PENA M WASSERLOUF M OROPELLO J BENJAMIN E DELGUIDICE R EMMANUEL G LIE T ANDERSON L MARSHALL J DEMAJO W ROTSTEIN O FOSTER D ABRAHAM E MIDDLETON H PERRY C LEVY H FRY DE SIMPSON SQ CROWELL RE NEIDHART M STEVENS D COFFMAN T NARASIMHAM N MERRICK DK BERGQUIST W MATZEL KE HUEBLER M FOULKE GE ALBERTSON TE WALBY WF ALLEN RP BAUGHMAN R HASSELGREN PO FINK MP FAVORITO F THOMPSON BT CORBIN R SHELLHORSE GY FRAZIER A WHITE S GARRARD C ACOURT C STORER S GERVICH DH FOSHE D BRASE R BAGDAHN A COONEY R SMITH JS MARTIN LF VINCENT JL FRIEDMAN G BERLOT G FLETCHER JR WILLIAMS MD WRIGHT TF JOHNSON S FEILD C WOLF K MACINTYRE N DUBIN HG DURKIN MR DUBIN PK STAUBACH KH FEIN AM SCHULMAN DB NIEDERMAN MS CHALFIN DB VANLEEUWEN PAM BOERMEESTER MA SCHNEIDER AJ BANDER J IMM A BERNARD G NELSON L STROUD M SAFCSAK K CERRA F RINDAL J MANN H HALPERN N SILVERSTEIN J ALICEA M SIBBALD WJ MARTIN CM RUTLEDGE FS PETTI K RUSSELL JA KRUGER R DRUMMOND A LANGE P SEIFERT T DUROCHER A TENAILLON A BOITEAU R LHERM T LOWRY SF COYLE SM BARIE PS DEMARIA E SNYDMAN DR SCHWAITZBERG SD NASRAWAY SA GRINDLINGER J SUMMER W DEBOISBLANC B WAHL M ALESTIG K GROSSMAN J MAKI D PAZ HL WEINER M BIHARI D CAMPBELL D BLEICHNER G DAHN MS LANGE MPA HALL J POHLMAN A WENZEL RP GROSSERODE M COSTIGAN M MILESKI W WEIGELT J YESTON N IRIZARRY C ROSS J ROBBINS J NIGHTINGALE P OWEN K SANDSTEDT S BERG S SIMON GL SENEFF MG CONRY KM ZIMMERMAN JL DELLINGER RP JOHNSTON R ALLEE P GRANDE PO MYHRE E DHAINAUT JF HAMY I MIRA JP HARMON J WHITE J MCKIE L SILVERMAN H TUMA P BENNETT D PORTER JC LAURELL MH JACOBS S ASH S STILES DM PRIOR MJ KNATTERUD G TERRIN M KUFERA J WILKENS P RA K MONROE L SPRUNG C HAMILTON CM MATTHAY R MCCABE W TONASCIA J WIEDEMAN H WITTES J CAMPION GV CROFT CR LUSTICK R LOOKABAUGH J GORDON GS NOE L BLOEDOW D SMITH CG BRANNON D KUSH R NG D MOORE E BAZEMORE K GALVAN M WAGNER D HARRELL F STABLEIN D
Citation: Cj. Fisher et al., RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF PATIENTS WITH SEPSIS SYNDROME - RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, JAMA, the journal of the American Medical Association, 271(23), 1994, pp. 1836-1843
UNPLANNED EXTUBATION - PREDICTORS OF SUCCESSFUL TERMINATION OF MECHANICAL VENTILATORY SUPPORT
Authors: WHELAN J SIMPSON SQ LEVY H
Citation: J. Whelan et al., UNPLANNED EXTUBATION - PREDICTORS OF SUCCESSFUL TERMINATION OF MECHANICAL VENTILATORY SUPPORT, Chest, 105(6), 1994, pp. 1808-1812
OXIMETER MALFUNCTION
Authors: LEVY H SERVILLA M SIMPSON SQ
Citation: H. Levy et al., OXIMETER MALFUNCTION, Chest, 105(3), 1994, pp. 975-975
BRONCHODILATING AGENTS INHIBIT TUMOR-NECROSIS-FACTOR-ALPHA GENE-EXPRESSION
Authors: FUNK LM SIMPSON SQ SINGH R BICE DE
Citation: Lm. Funk et al., BRONCHODILATING AGENTS INHIBIT TUMOR-NECROSIS-FACTOR-ALPHA GENE-EXPRESSION, The American review of respiratory disease, 147(4), 1993, pp. 980-980
Risultati: 1-16 |